# A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus

> **NCT05110846** · PHASE2 · COMPLETED · sponsor: **Carmot Therapeutics, Inc.** · enrollment: 103 (actual)

## Conditions studied

- Obesity
- Overweight
- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Placebo
- **DRUG:** CT-868

## Key facts

- **NCT ID:** NCT05110846
- **Lead sponsor:** Carmot Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-22
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-02-28
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05110846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05110846, "A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05110846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*